Table 5 Distribution of VF genes in relation to fluoroquinolone (FQ) resistance status among E. coli ST131 isolates from men
Trait | Number (%) of isolates with trait by source and ST131 status | P value by isolate source (vs. ST131)a | ||||
|---|---|---|---|---|---|---|
Fecal (n = 8) | Clinical (n = 49) | |||||
FQ-R-ST131 (n = 5) | FQ-S-ST131 (n = 3) | FQ-R-ST131 (n = 27) | FQ-S-ST131 (n = 22) | Fecal | Clinicalb | |
ESBL | 2 (40) | 0 (0) | 18 (67) | 10 (45) |  < 0.001 |  < 0.001 |
O25b | 5 (100) | 3 (100) | 22 (82) | 21 (96) | NS | NS |
O16 | 0 (0) | 0 (0) | 5 (19) | 1 (4) | NS | < 0.001 |
VF genesc | ||||||
afa/draBC | 1 (20) | 0 (0) | 1 (4) | 4 (18) | NS | < 0.001 |
bmaE | 0 (0) | 0 (0) | 1 (4) | 0 (0) | NS | NS |
sfaS | 1 (20) | 0 (0) | 2 (7) | 5 (23) | NS | < 0.001 |
fimH | 5 (100) | 3 (100) | 27 (100) | 22 (100) | NS | NS |
focG | 1 (20) | 1 (33) | 18 (67) | 6 (27) | 0.031 | < 0.001 |
papGI | 0 (0) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
papGII | 1 (20) | 1 (33) | 8 (30) | 3 (14) | 0.031 | < 0.001 |
papGIII | 1 (20) | 1 (33) | 8 (30) | 4 (18) | 0.039 | < 0.001 |
papAH | 1 (20) | 1 (33) | 16 (59) | 6 (27) | 0.030 | < 0.001 |
papC | 1 (20) | 1 (33) | 15 (56) | 7 (32) | NS | < 0.001 |
papEF | 1 (20) | 1 (33) | 16 (59) | 7 (32) | NS | < 0.001 |
gafD | 0 (0) | 0 (0) | 1 (4) | 0 (0) | NS | NS |
cnf1 | 1 (20) | 1 (33) | 17 (63) | 8 (36) | NS | < 0.001 |
hlyA | 1 (20) | 1 (33) | 18 (67) | 6 (27) | NS | < 0.001 |
iutA | 5 (100) | 3 (100) | 27 (100) | 22 (100) | NS | NS |
fyuA | 3 (60) | 2 (67) | 27 (100) | 16 (73) | NS | 0.01 |
iroN | 2 (40) | 1 (33) | 22 (81) | 9 (41) | NS | < 0.001 |
kpsMTII | 1 (20) | 1 (33) | 13 (48) | 22 (100) | 0.027 | NS |
KpsMTIII | 0 (0) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
traT | 5 (100) | 3 (100) | 27 (100) | 22 (100) | NS | NS |
ompT | 5 (100) | 3 (100) | 27 (100) | 22 (100) | NS | NS |
usp | 5 (100) | 3 (100) | 27 (100) | 22 (100) | NS | NS |